News
Thrive Health Solutions also faces a lawsuit from drugmaker Eli Lilly, for allegedly making false claims about FDA approval when selling compounded version of tirzepatide.
Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...
Lilly Endowment Community Scholarship application is now available in Carroll County through the. The Lilly Endowment Community Scholarship Program (LECSP) will provide 147 scholarships ...
Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging. The ...
Doctors say the situation forces them to get creative in treating patients, but there’s hope that prices may fall more in the ...
New data and analyses presented at the American Diabetes Association’s annual meeting highlight the priorities for the next ...
Health and Human Services Secretary Robert F. Kennedy Jr. lambasted federal agencies he accused of being overly influenced by ...
A review found just under half of the claimed spending originated under Joe Biden or represented routine spending repackaged ...
Armed with the latest biological knowledge and cutting-edge computational techniques—and, of course, investor dollars—these ...
This week, Phil Oakley has analysed two shares, DexCom (US:DXCM) and Auto Trader (AUTO), which have decent earnings growth forecasts but rich valuations. It looks like both companies will need ...
The U.S. Food and Drug Administration approved changing the prescribing information for Eli Lilly's Alzheimer's drug Kisunla to allow more gradual dosing to lower the risk of a potentially dangerous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results